Brief: Bliss GVS Pharma says Palghar plant inspection completed without deficiencies
Nov 2 (Reuters) - Bliss Gvs Pharma Ltd BLIS.NS
* Says successful completion of EU-GMP inspection at
Palghar
plant
* Says inspection completed without any deficiencies
Source text - http://bit.ly/2ioDEaT
Further company coverage: BLIS.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Bliss GVS Pharma
See all newsBrief: Bliss GVS Pharma June-Quarter Consol Net Profit 501 Million Rupees
Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
India's Bliss GVS Pharma gains on Anupam Rasayan's plan to buy stake
Brief: Bliss GVS Pharma Dec-Quarter Consol Net Profit 232.7 Million Rupees